Revisitation of an old antimalarial to combat Psoriatic Arthritis administering an antidote to Santonin to avoid xanthopsia or maculopathy
Background: The mechanism of action of antimalarials in the treatment of patients with rheumatoid arthritis is hitherto unknown but is thought to involve changes in antigen presentation or effects on the innate immune system. Material and Methods: Patient with psoriatic artritis after ineffective...
Main Author: | Lorenzo Martini |
---|---|
Format: | Article |
Language: | English |
Published: |
Our Dermatology Online
2018-07-01
|
Series: | Nasza Dermatologia Online |
Subjects: | |
Online Access: | http://www.odermatol.com/issue-in-html/2018-3-8-psoriatic/ |
Similar Items
-
Mimicking Metabolism of a Reversed Chloroquine Antimalarial
by: Kendrick, Kelsie Lynn
Published: (2014) -
Antimaláricos e Ototoxicidade Antimalarials and Ototoxicity
by: Marcelo Cardoso Figueiredo, et al.
Published: (2004-06-01) -
Design and Synthesis of Novel Chloroquine-based Antimalarials
by: Murphy, Kevin Vincent
Published: (2015) -
Psychosis consequent to antimalarial drug use in a young child
by: Jitender Aneja, et al.
Published: (2019-01-01) -
Retinal toxicity induced by antimalarial drugs: literature review and case report
by: Manuel Garza-Leon, et al.
Published: (2016-06-01)